Skip to main content

Articles By Robert Chao, MD

ACR meeting education

ACR22 Takeaways: Pre-RA, Lupus, PsA and AS

29 November 2022

ACR22 Convergence left us bountiful with information from all over the world. Here are a few of my personal highlights and key takeaways. 

Read Article
pills-384846_640%20%281%29.jpg

The complexity of opioid use in spondyloarthritis

14 November 2022

A few things we know about opioids: use is common; it’s not efficacious in the treatment of spondyloarthritis; and, there is an opioid epidemic and its users are stigmatized. Abstract 0402 is a retrospective study that looked at patients with psoriatic arthritis or ankylosing spondylitis in the FORWARD databank. It sheds new light and leaves us with some food for thought

Read Article
Convention2.jpg

AS, Lupus and Subclinical RA: What I'm looking forward to at ACR22

10 November 2022

As we approach ACR22, there are many things to be excited about, especially with the reintroduction of in-person attendance. My attention this year is in research being presented in these three areas: ankylosing spondylitis; lupus management and treatment; and, subclinical RA.

Read Article
covid coronavirus virus

Spondyloarthritis and COVID-19

15 June 2022

There are still questions surrounding COVID-19, and some common questions I receive from patients revolve around what to do with their current DMARDs or should they even start treatment during this pandemic. Two studies focused on this question. 

Read Article
Back Pain

JAKi for nonradiographic axSpA

01 June 2022

One area of continued interest for many rheumatologists is the field of non-radiographic axial spondyloarthritis. Furthermore, the question of the utility of JAK inhibitors for the treatment of axial spondyloarthritis has been on the rise. 

Read Article
heel enthesitis spur calcaneal

The Enthesitis Challenge in Psoriatic Arthritis

06 April 2022

A colleague of mine once told me an interesting story of how her father, who was a doctor, misdiagnosed his wife with fibromyalgia when she actually had psoriatic arthritis with enthesitis all along. I would venture out and say that the average physician would have trouble evaluating enthesitis because even we, as rheumatologists do! 

Read Article
switch.jpg

Monitoring Infliximab Drug Levels Improves Efficacy

08 December 2021

Should we start considering therapeutic drug monitoring when prescribing TNFi for treatment of our rheumatologic conditions?

Read Article
pso.arm_.JPG

Risankizumab for Active Psoriatic Arthritis

26 November 2021

The arsenal of therapeutics for psoriatic arthritis continues to increase. Risankizumab is an IL-23 inhibitor to the p19 subunit, currently being investigated for treatment of psoriatic arthritis.

Read Article
switch.jpg

Monitoring Infliximab Drug Levels Improves Efficacy

09 November 2021

Should we start considering therapeutic drug monitoring when prescribing TNFi for treatment of our rheumatologic conditions?

Read Article
pso.arm_.JPG

Risankizumab for Active Psoriatic Arthritis

06 November 2021

The arsenal of therapeutics for psoriatic arthritis continues to increase. Risankizumab is an IL-23 inhibitor to the p19 subunit, currently being investigated for treatment of psoriatic arthritis.

Read Article
×